Silver Book Fact

Between 1998 and 2008, the rate of death attributable to cardiovascular disease declined 30.6%.

Roger V, Go A, Lloyd-Jones D, Benjamin E, et al. Heart Disease and Stroke Statistics–2012 Update. Circ. 2012; 125(1): e2-e220. http://circ.ahajournals.org/content/125/1/e2

Reference

Title
Heart Disease and Stroke Statistics–2012 Update
Publication
Circ
Publisher
American Heart Association
Publication Date
2012
Authors
Roger V, Go A, Lloyd-Jones D, Benjamin E, et al.
Volume & Issue
Volume 125, Issue 1
Pages
e2-e220
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Direct thrombin inhibitor reduced relative risk of venous thromboembolism
    An investigational direct thrombin inhibitor reduced relative risk of venous thromboembolism after total hip replacement surgery by 65.7%—compared to a currently available treatment.  
  • Undertreatment of patients with sSAS
    AS is often undertreated — one study found that 56% of severe symptomatic aortic stenosis (sSAS) patients referred to a cardiothoracic surgeon were not operated on.  
  • Using technologies as treatment for heart disease helps generate cost savings, including a total of $1930 annual savings per person, and a $1.5 billion increased tax revenue  
  • Glycoprotein inhibitors have been shown to reduce the risk of death, a second heart attack, or the need for revascularization by 48% to 52% in patients who have suffered a…  
  • If all forms of cardiovascular disease were eliminated, life expectancy would rise by almost 7 years.